aid: alterome-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alterome-therapeutics.png
name: Alterome Therapeutics
description: Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021
  and headquartered in San Diego, California, backed by Canaan Partners. The company designs
  alteration-specific cancer therapies using deep biology and chemistry expertise paired with an
  in-house computational chemistry platform ("The Kraken"), a custom CPU/GPU compute array for
  physics-based molecular simulation and drug design. Its clinical pipeline includes ALTA2618, a
  mutation-selective inhibitor for AKT1 E17K-driven cancers, and ALTA3263, an oral pan-KRAS ON-state
  inhibitor targeting more than 90% of KRAS mutations in cancer. Alterome was surfaced through the
  Canaan Partners portfolio and added to the API Evangelist network as a company profile; it publishes
  no public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/alterome-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Drug Discovery
- Computational Chemistry
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.alterome.com/
- type: About
  url: https://www.alterome.com/about/
- type: Blog
  url: https://www.alterome.com/news/
- type: TermsOfService
  url: https://www.alterome.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.alterome.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/alterome
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence